MARKET

CMPS

CMPS

COMPASS Pathways plc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

43.17
+3.23
+8.09%
After Hours: 43.20 +0.03 +0.07% 19:51 09/25 EDT
OPEN
40.29
PREV CLOSE
39.94
HIGH
44.23
LOW
40.00
VOLUME
1.00M
TURNOVER
--
52 WEEK HIGH
44.23
52 WEEK LOW
22.51
MARKET CAP
1.47B
P/E (TTM)
-37.8485
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
COMPASS Pathways announces closing of initial public offering of American Depositary Shares and full exercise of underwriters’ option to purchase additional American Depositary Shares
COMPASS Pathways announces closing of initial public offering of American Depositary Shares and full exercise of underwriters’ option to purchase additional American Depositary SharesLondon, UK – September 22, 2020COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated
GlobeNewswire · 5d ago
First Psychedelic Drug Stock Hits $1 Billion In Debut After Upsized IPO
Investor's Business Daily · 09/18 20:19
Compass Pathways' stock debuts with a rally, as the first trade was 38% above the IPO price
Shares of Compass Pathways PLC undefined pointed north out of the gate, as the first trade was 37.6% above the initial public offering price. The U.K.-based...
MarketWatch · 09/18 16:33
COMPASS Pathways announces pricing of upsized initial public offering
COMPASS Pathways announces pricing of upsized initial public offeringLondon, UK – September 18, 2020COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the pricing of its
GlobeNewswire · 09/18 02:40
Forecast
EPSBVPSCFPS
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CMPS. Analyze the recent business situations of COMPASS Pathways plc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
  • Performance
  • Asset Allocation
  • Dividend History
No Data
No Data
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About CMPS
COMPASS Pathways PLC is a mental health care company. The Company is focused on developing treatments for people suffering with mental health challenges. It is initially focused on treatment-resistant depression (TRD). It is developing COMP360, a polymorphic crystalline formulation of psilocybin. Its COMP360 psilocybin therapy comprises administration of its COMP360 with psychological support from specially trained therapists with specific professional and educational qualifications. The psilocybin administration session lasts approximately six to eight hours, with patients supported by therapists in a non-directive manner. The psilocybin administration sessions are preceded by preparation sessions, in which patients are given a thorough orientation, and followed by integration sessions to help patients process the range of emotional and physical experiences facilitated by COMP360. The Company is developing COMP360 in conjunction with psychological support in a Phase-IIb trial.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of COMPASS Pathways PLC stock information, including NASDAQ:CMPS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CMPS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CMPS stock methods without spending real money on the virtual paper trading platform.